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Abstract
Background: Measures of abdominal adiposity are strongly associated with all-cause mortality and cardiovascular
disease (CVD). However, data are limited and conflicting regarding the consequences of changes in body fat
distribution. The main aims of this paper are to investigate the association between changes in waist circumference
(WC) and all-cause and CVD mortality and to examine these changes in relation to concurrent changes in weight.
Methods: The European Prospective Investigation into Cancer and Nutrition (EPIC-Norfolk) study recruited 25,639
participants between 1993 and 1997, aged 39–79, a number of whom also attended a second examination (1998–
2000), and were followed up to 2016 for mortality. Participants were eligible for inclusion if they had WC, weight
and height measurements at both time-points; those with a self-reported history of CVD or cancer, body mass
index < 18.5 kg/m2 or missing data on covariates were excluded, leaving 12,337 participants for analyses. The
median (IQR) follow-up time was 16.4 (15.7, 17.2) years. Hazard Ratios (HRs) for all-cause (2866 deaths) and CVD
mortality (822 deaths), by categories of WC change, were determined using Cox proportional hazards analyses.
Results: After multivariable adjustment, the HRs (95% CIs) for all-cause mortality for men and women with a WC
gain (WCG) > 5 cm were 1.51 (1.29–1.75) and 1.25 (1.06–1.46) respectively. For CVD mortality in men and women
with a WCG > 5 cm, the HRs were 1.84 (1.39–2.43) and 1.15 (0.85–1.55) respectively. In analyses of concurrent
changes in WC and weight, the greatest risk (HRs) (95% CIs) in men occurred with weight loss and WCG: 1.80 (1.13–
2.86) for all-cause and 2.22 (1.03–4.82) for CVD mortality. In women, the greatest risk for both all-cause (HR 1.50
(1.16–1.95)) and CVD mortality (HR 1.81 (1.15–2.85)) was observed in those with weight loss and maintenance of
WC (WCM).
Conclusions: Objectively measured WCG > 5 cm, was associated with subsequent higher total mortality risk and
higher CVD mortality risk in men. Interventions focusing on preventing increase in central adiposity rather than
lowering weight per se in later life may potentially have greater health benefits.
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Background
Obesity is a major risk factor for many chronic diseases,
such as diabetes, cardiovascular disease (CVD) and certain
cancer types, as well as mortality [1–3], and is commonly
defined using body mass index (BMI) [4]. However, BMI
does not take into account the distribution of the fat mass,
which is of particular importance in older individuals, as the
distribution of body fat changes with age [5]. Waist circum-
ference (WC) strongly correlates with abdominal obesity
and is a commonly used clinical measure of body fat distri-
bution [6, 7]. Studies have shown that WC is associated with
CVD risk [8–10] and CVD mortality [11]. WC has also been
positively associated with all-cause mortality in a number of
studies [12–18] with a few exceptions [19, 20]. The presence
of central or abdominal obesity, as defined by a high WC, is
one of five components used in the clinical diagnosis of the
metabolic syndrome [21], which is associated with an in-
creased risk of developing type 2 diabetes, CVD and subse-
quent mortality [22].
However, there are limited and conflicting data avail-
able regarding the consequences of changes in body fat
distribution. A number of studies have found a gain in
WC (WCG) to be predictive of subsequent all-cause and
CVD mortality [23, 24] but a prospective cohort study
found that WC loss (WCL) was associated with an in-
creased risk of all-cause mortality, particularly for older
adults [25]. However, no association was found between
changes in WC and mortality in Swedish women [26],
elderly Brazilians [27] or Iranian men [28].
Data pooled from 15 prospective studies that included
258,114 individuals, has found that a 1 cm increase in WC
is associated with a 2% increased risk of future CVD [29].
In England, among women, the mean WC increased from
81.7 cm in 1993 to 88.1 cm in 2016, and the percentage
with a very high WC (> 88 cm) rose from 26 to 46%;
among men, the mean WC increased from 93.2 cm in
1993 to 97.0 cm in 2016, and the percentage with a very
high WC (> 102 cm) increased from 20 to 34% [30].
We have recently reported that objectively measured
weight loss (WTL), but not weight gain (WTG), was associ-
ated with subsequent higher mortality in healthy, middle-
aged and elderly community-dwelling men and women,
compared to those who maintained their weight (WTM)
[31]. The main aim of this paper is therefore to investigate
the association between changes in WC and all-cause and
CVD mortality. A secondary aim is to examine these
changes in relation to concurrent changes in weight as pre-
vious studies have tended to focus on either changes in
WC or weight but not changes in both concurrently.
Methods
Study design
The European Prospective Investigation Into Cancer and
Nutrition (EPIC) is large diet and cancer cohort [32].
The EPIC-Norfolk study participants, aged between 39
and 79 years, were recruited from 35 General Practi-
tioners’ surgeries in the Norfolk area of East Anglia,
from 1993 to 1997 [33]. General practice age sex regis-
ters act as a population sampling frame as practically all
of the UK the population are registered with a general
practice through the National Health Service. Many of
the characteristics of this cohort at baseline were com-
parable to the UK national population, including age,
sex and anthropometry measurements but this cohort
had a lower proportion of current smokers [34].
Ethical approval for the study was given by the Nor-
wich District Health Authority Ethics Committee and all
participants gave written, informed consent.
Main exposure: change in waist circumference
Of those who consented to take part in the study (N =
30,445), 25,639 attended a baseline health examination
(1HE) (1993–1997) and 15,786 attended a second health
examination (2HE) (1998–2000).
Trained nurses measured participants’ weight and
height, with participants wearing light clothing and with-
out shoes. Weight was measured to the nearest 100 g
using digital scales (Salter, UK). Height was measured to
the nearest 0.1 cm using a free-standing stadiometer. A
D-loop non-stretch fibreglass tape was used to measure
WC, which was measured at the smallest circumference
between the ribs and iliac crest to the nearest 0.1 cm
while the participant was standing erect, with the abdo-
men relaxed, the arms at the side, the feet together and
at the end of a normal expiration, without the tape com-
pressing the skin. The measurement was taken at the
level of the umbilicus where there was no natural waist-
line. Body mass index (BMI) is defined as the body mass
(weight) divided by the square of the height, and is
expressed in kg/m2, and is commonly used to categorise
individuals as underweight (< 18.5 kg/m2), normal
weight (≥18.5 to < 25 kg/m2), overweight (≥25 to 30 kg/
m2), or obese (≥ 30 kg/m2) [4].
Absolute change in WC (cm) was calculated as WC
measured at 2HE minus WC at 1HE. Absolute weight
change (kg) was calculated as weight measured at 2HE
minus weight measured at 1HE. Participants were
assigned to one of five WC change categories: > 5 cm
loss, > 2.5 to ≤5 cm loss, ≤ 2.5 cm loss or gain (‘mainten-
ance’, including zero change; considered the reference
category), > 2.5 to ≤5 cm gain, > 5 cm gain. Annual WC
change was calculated from the absolute difference in
WC, divided by the participants’ time lapse between the
health examinations (cm/y).
In order to study the possible association between
changes in WC and changes in weight, participants were
assigned to one of nine categories, based on a loss of >
2.5 cm or 2.5 kg, within 2.5 cm or 2.5 kg loss or gain
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(maintenance), or a gain of > 2.5 cm or 2.5 kg respect-
ively. The nine categories were as follows: WTM (weight
maintenance) and WCM (WC maintenance) (reference
category); WTL (weight loss) and WCL (WC loss); WTL
and WCM; WTL and WCG (WC gain); WTM and
WCL; WTM and WCG; WTG (weight gain) and WCL;
WTG and WCM; and WTG and WCG.
Participant selection
Measurements of WC, weight and height measurements
at both time-points were essential for participant inclu-
sion (N = 15,010). Participants were excluded from
analyses if they were categorised as underweight (BMI <
18.5 kg/m2) or who self-reported CVD or cancer at ei-
ther examination (N = 2095); those with missing data on
adjustment variables (smoking, social class, educational
level, physical activity, and menopausal status in women
(N = 529) were also excluded. This left 12,337 partici-
pants for analyses (Fig. 1).
Adjustment variables
Data from two self-administered Health and Lifestyle Ques-
tionnaires (HLQ1 and HLQ2), at 1HE and 2HE respectively,
were used to create categories of a number of variables.
Current smokers were defined as those currently smoking
cigarettes, former smoker as being a smoker previously and
non-smokers were those who never smoked (derived from
HLQ1 and HLQ2). Self-reported physical activity (derived
from HLQ1) was classified into four levels, using both occu-
pational and leisure activity: inactive, moderately inactive,
Fig. 1 Study population and sample size eligible for mortality analyses
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moderately active and active [35, 36]. Social class at 1HE
was defined according to the Registrar General’s
occupation-based classification scheme and categorised into
the following six groups: professional, managerial and tech-
nical, non-manual skilled, manual skilled, partly skilled and
unskilled [37]; for our analyses, these categories were com-
bined to create 2 categories, non-manual (professional, man-
agerial and technical, non-manual skilled) and manual
(manual skilled, partly skilled and unskilled). Educational
status at 1HE was categorised into four groups: degree or
equivalent, A level or equivalent, O level or equivalent and
less than O level or no qualification, corresponding to levels
within the International Standard Classification of Education
1997 [38]. In our analyses, those with an educational level of
O level and above were combined into one category. Meno-
pausal status was categorised as premenopausal, early peri-
menopausal (< 1 year), late perimenopausal (1–5 years) or
postmenopausal (> 5 years). Included adjustment variables
were measured with HLQ1, with the exceptions of smoking
status and menopausal status, which were measured with
HLQ2. Participants were asked about their medical histories
at both time-points. The diagnosis of chronic diseases such
as heart attack, stroke and cancer were recorded as present
when participants answered “yes” to question “Has a doctor
ever told you that you have any of the following
conditions?”
Endpoints
All fatal events occurring between 1998 and 31st March
2016 were captured by the Office of National Statistics,
United Kingdom. Death certificates were coded by
nosologists according to the International Classification
of Diseases (ICD). An underlying cause of death from
cancer or CVD was defined by using the following ICD
codes: cancer death (ICD9, 140–208 or ICD10 C00-
C97), or CVD death (ICD9 400–438 or ICD10 I10-I79).
Statistical analyses
Characteristics of the study population were summarised
by WC change category, for continuous variables (mean
and SD) and categorical variables (frequency and per-
centage). The follow-up time began at the 2HE and
formed the underlying time variable; median (IQR)
follow-up time was 16.4 (15.7, 17.2) years. Participants
who died were censored at their date of death and those
who did not die were censored at the end of follow-up
(31st March 2016). Three Cox proportional hazards
models were used to determine Hazard Ratios (HRs) for
all-cause and CVD mortality by WC change category for
men and women separately: age (continuous variable),
(model 1); including BMI (continuous variable), WC
(continuous variable), physical activity, social class, edu-
cational level, smoking (2HE) and menopausal status
(2HE) in women (model 2); and including difference in
weight (continuous variable) (model 3). The propor-
tional hazards’ assumption was tested by including time
interaction variables in the Cox regression models and
we found that age violated our test (P < 0.0001). How-
ever, when the time interaction for age was included,
only minimal changes to the HRs of WC change were
observed, so results are shown with age adjustment
alone. We also examined HRs by WC change category,
separately in men and women, in subgroups, stratified
by age, WC, smoking status, BMI, physical activity, edu-
cational level, social class, menopausal status in women,
and after the exclusion of individuals who died within 3
or 5 years of the 2HE. The data were analysed using
Stata 14 (STATA Corp., Texas, USA).
Results
Description of the cohort
Over a 3.5 year period, men had a mean WC and weight
increase of 0.83 cm (SD 5.19) and 1.29 kg (SD 3.61) re-
spectively; similar mean increases of 0.81 cm (SD 5.60)
in WC and 1.38 kg (SD 4.14) in weight were found in
women. The baseline characteristics of those who
attended both 1HE and 2HE, before and after exclusions
were applied were similar (Additional file 1: Table S1).
However, the prevalence of self-reported CVD and the
percentages of current smokers and physically inactive
participants were higher in those who attended the 1HE
only, compared to those who also attended the 2HE.
Also, the percentage of deaths that occurred was lower
in both men and women, after exclusion criteria were
applied, with the highest percentage found in those who
only attended the 1HE.
Table 1 describes the characteristics of men and
women, by WC change category. WCM was observed in
40% of men and 38% of women. Participants with the
greatest WCL were, on average, older and had the lar-
gest WC, weight and BMI at 1HE. Men with the greatest
WCG were more likely to have a smaller WC at 1HE,
whereas women with the greatest WCG had a similar
WC at 1HE, compared to those in the WCM category.
Current smokers at 2HE were more likely to have a
WCL whereas former smokers, a WCG. Male non-
manual workers were more likely to have a WCL > 5 cm
whereas male manual workers were more likely to have
a WCG > 5 cm. Participants with no qualifications were
more likely to have a WCG > 5 cm. A greater percentage
of deaths occurred in those with a WCL > 5 cm.
Main analyses: total and CVD mortality
At the end of a median (IQR) follow-up time of 16.4
(15.7, 17.2) years, 1551 deaths in men and 1315 deaths
in women were recorded, 440 and 382 deaths from
CVD, respectively. Total and CVD mortality HRs for
men and women by WC change category are shown in
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Table 1 Characteristics at 1st and 2nd health examinations of 5469 men and 6868 women, stratified by categories of change in
waist circumference
Categories of change in waist circumference (WC) (cm)
Loss > 5 cm Loss > 2.5 and ≤ 5 cm Loss or gain ≤2.5 cm Gain > 2.5 and ≤ 5 cm Gain > 5 cm All
MEN, N (row %) 641 (11.7) 656 (12.0) 2211 (40.4) 926 (16.9) 1035 (18.9) 5469 100.0%
WC at 1HE (cm) 99.0 9.2 96.8 9.1 95.3 8.9 93.8 8.6 92.4 9.7 95.1 9.3
WC at 2HE (cm) 91.0 9.2 93.2 9.1 95.4 8.9 97.6 8.6 100.5 10.0 96.0 9.6
WC change (cm) −8.0 3.1 −3.7 0.7 0.1 1.4 3.8 0.7 8.1 2.9 0.8 5.2
Annual WC
change (cm)
−2.3 1.0 −1.1 0.3 0.0 0.4 1.1 0.3 2.2 0.9 0.2 1.5
Age at 1HE (years) 59.6 9.3 59.7 9.0 58.8 8.9 58.7 8.9 58.6 8.7 58.9 8.9
Age at 2HE (years) 62.8 9.4 62.8 9.1 61.9 9.0 61.9 9.0 61.8 8.7 62.1 9.0
Age change (years) 3.2 0.8 3.1 0.8 3.1 0.8 3.2 0.8 3.3 0.8 3.2 0.8
Weight at 1HE (kg) 81.7 10.7 80.4 10.9 80.0 10.8 79.8 10.2 80.2 11.7 80.2 10.9
Weight at 2HE (kg) 79.0 10.5 79.9 11.0 81.0 11.2 82.4 10.7 84.4 12.8 81.5 11.5
Weight change (kg) −2.7 3.6 −0.5 2.9 1.1 2.6 2.6 2.7 4.2 3.5 1.3 3.6
BMI at 1HE (kg/m2) 26.8 3.2 26.5 3.1 26.3 3.1 26.2 3.0 26.3 3.3 26.3 3.1
BMI at 2HE (kg/m2) 26.0 3.1 26.4 3.2 26.7 3.2 27.1 3.1 27.8 3.6 26.9 3.3
BMI change (kg/m2) −0.8 1.2 −0.1 0.9 0.4 0.9 0.9 0.9 1.5 1.2 0.5 1.2
Education - 1HE
None 172 26.8 164 25.0 573 25.9 248 26.8 287 27.7 1444 26.4%
O level and above 469 73.2 492 75.0 1638 74.1 678 73.2 748 72.3 4025 73.6%
Social class - 1HE
Non-manual 412 64.3 414 63.1 1352 61.2 585 63.2 632 61.1 3395 62.1%
Manual 229 35.7 242 36.9 859 38.8 341 36.8 403 38.9 2074 37.9%
Smoking status - 1HE
Current 66 10.3 60 9.2 185 8.4 86 9.3 110 10.6 507 9.3%
Former 321 50.1 341 52.0 1200 54.3 477 51.5 559 54.0 2898 53.0%
Never 254 39.6 255 38.9 826 37.4 363 39.2 366 35.4 2064 37.7%
Smoking status - 2HE
Current 67 10.5 59 9.0 166 7.5 65 7.0 81 7.8 438 8.0%
Former 320 49.9 342 52.1 1221 55.2 498 53.8 589 56.9 2970 54.3%
Never 254 39.6 255 38.9 824 37.3 363 39.2 365 35.3 2061 37.7%
Physical activity - 1HE
Inactive 193 30.1 160 24.4 601 27.2 233 25.2 257 24.8 1444 26.4%
Moderately inactive 163 25.4 196 29.9 529 23.9 216 23.3 249 24.1 1353 24.7%
Moderately active 156 24.3 159 24.2 541 24.5 249 26.9 272 26.3 1377 25.2%
Active 129 20.1 141 21.5 540 24.4 228 24.6 257 24.8 1295 23.7%
Deaths during follow-up 218 34.0 196 29.9 585 26.5 246 26.6 306 29.6 1551 28.4%
Lost weight in
last 5 years (2HE)
Diet 61 22.9 42 15.8 92 34.6 28 10.5 43 16.2 266 4.9%
Illness 28 21.7 7 5.4 51 39.5 17 13.2 26 20.2 129 2.4%
WOMEN, N (row %) 873 (12.7) 875 (12.7) 2596 (37.8) 1131 (16.5) 1393 (20.3) 6868 100.0%
WC at 1HE (cm) 87.2 11.4 82.6 10.5 80.0 9.5 79.1 9.7 79.6 9.2 81.0 10.2
WC at 2HE (cm) 78.8 10.7 78.9 10.5 80.1 9.6 82.8 9.7 88.0 10.0 81.9 10.5
WC change (cm) −8.4 3.5 −3.7 0.8 0.1 1.4 3.7 0.7 8.4 3.3 0.8 5.6
Annual WC change (cm) −2.4 1.2 −1.1 0.3 0.0 0.4 1.1 0.3 2.4 1.1 0.2 1.6
Age at 1HE (years) 58.7 9.0 58.5 9.2 58.0 8.9 57.4 8.6 57.5 8.5 58.0 8.8
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Table 2. The addition of change in weight to the model
strengthened the positive WCG-mortality associations
(model 3), especially in men, where the findings for
CVD mortality were stronger than for all-cause mortal-
ity, in those with a WCG > 5 cm (HR 1.84 and 1.51
respectively). Women with a WCG > 5 cm had a signifi-
cantly higher hazard of all-cause mortality of 1.25 (CI
1.06–1.46) compared to WCM. No significant associa-
tions were found regarding changes in WC and CVD
mortality in women. No significant associations were
Table 1 Characteristics at 1st and 2nd health examinations of 5469 men and 6868 women, stratified by categories of change in
waist circumference (Continued)
Categories of change in waist circumference (WC) (cm)
Loss > 5 cm Loss > 2.5 and ≤ 5 cm Loss or gain ≤2.5 cm Gain > 2.5 and ≤ 5 cm Gain > 5 cm All
Age at 2HE (years) 61.9 9.2 61.6 9.3 61.2 9.0 60.5 8.6 60.6 8.6 61.1 8.9
Age change (years) 3.1 0.8 3.2 0.8 3.1 0.8 3.1 0.8 3.2 0.8 3.2 0.8
Weight at 1HE (kg) 70.1 12.8 67.8 11.7 66.2 10.4 66.7 10.6 68.5 10.7 67.5 11.1
Weight at 2HE (kg) 67.7 12.1 67.3 11.7 67.3 10.8 69.2 11.2 73.0 12.0 68.9 11.6
Weight change (kg) −2.4 4.8 −0.5 3.3 1.1 2.9 2.5 3.2 4.5 4.2 1.4 4.1
BMI at 1HE (kg/m2) 26.9 4.6 26.0 4.3 25.5 3.8 25.6 3.9 26.3 3.9 25.9 4.0
BMI at 2HE (kg/m2) 26.1 4.3 26.0 4.4 26.0 4.0 26.6 4.2 28.1 4.4 26.6 4.3
BMI change (kg/m2) −0.8 1.8 −0.1 1.2 0.5 1.1 1.0 1.2 1.9 1.6 0.7 1.6
Education - 1HE
None 291 33.3 321 36.7 983 37.9 402 35.5 528 37.9 2525 36.8%
O level and above 582 66.7 554 63.3 1613 62.1 729 64.5 865 62.1 4343 63.2%
Social class - 1HE
Non-manual 537 61.5 558 63.8 1659 63.9 727 64.3 877 63.0 4358 63.4%
Manual 336 38.5 317 36.2 937 36.1 404 35.7 516 37.0 2510 36.6%
Smoking status - 1HE
Current 94 10.8 72 8.2 224 8.6 100 8.8 128 9.2 618 9.0%
Former 290 33.2 287 32.8 794 30.6 329 29.1 469 33.7 2169 31.6%
Never 489 56.0 516 59.0 1578 60.8 702 62.1 796 57.1 4081 59.4%
Smoking status - 2HE
Current 88 10.1 70 8.0 206 7.9 76 6.7 105 7.5 545 7.9%
Former 297 34.0 289 33.0 814 31.4 353 31.2 494 35.5 2247 32.7%
Never 488 55.9 516 59.0 1576 60.7 702 62.1 794 57.0 4076 59.4%
Physical activity - 1HE
Inactive 234 26.8 236 27.0 622 24.0 245 21.7 369 26.5 1706 24.8%
Moderately inactive 282 32.3 275 31.4 874 33.7 390 34.5 457 32.8 2278 33.2%
Moderately active 220 25.2 206 23.5 631 24.3 291 25.7 328 23.6 1676 24.4%
Active 137 15.7 158 18.1 469 18.1 205 18.1 239 17.2 1208 17.6%
Deaths during follow-up 212 24.3 181 20.7 487 18.8 176 15.6 259 18.6 1315 19.2%
Menopausal
status (2HE)
Pre-menopausal 51 5.8 55 6.3 170 6.6 67 5.9 86 6.2 429 6.3%
Early peri-menopausal 26 3.0 34 3.9 80 3.1 63 5.6 48 3.5 251 3.7%
Late peri-menopausal (1–5 y) 149 17.1 168 19.2 504 19.4 213 18.8 288 20.7 1322 19.3%
Post-menopausal (> 5 y) 647 74.1 618 70.6 1842 71.0 788 69.7 971 69.7 4866 70.9%
Lost weight in
last 5 years (2HE)
Diet 179 23.6 108 14.3 233 30.8 94 12.4 143 18.9 757 11.0%
Illness 33 19.5 25 14.8 62 36.7 26 15.4 23 13.6 169 2.5%
Values are mean and SD or frequency and percentage
1HE 1st health examination, 2HE 2nd health examination, BMI body mass index
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found for WCL and total or CVD mortality in the multi-
variate adjusted models, in either men or women.
Subgroup analyses
HRs for all-cause mortality in men and women, adjusted as
per model 3, grouped by confounder categories are shown
in Tables 3 and 4 respectively. Participants with a WCG> 5
cm had a higher HR than those in the WCM category, irre-
spective of their WC categorisation at 1HE, although stron-
ger associations were more evident in men. Men who had a
WCG> 5 cm had significantly higher HRs, irrespective of
whether they were < 65 years (HR 1.78 CI 1.40–2.26) or >
65 years (HR 1.38 (CI 1.13–1.68) of age at 1HE (Table 3) al-
though a significant association was only found among
women > 65 years (HR 1.35 (CI 1.10–1.67) (Table 4). Higher
hazards were observed for participants with a WCG> 5 cm,
irrespective of smoking status, with the exception of women
who were former smokers, where a WCG between 2.5 and
5 cm had a significantly lower HR of 0.62 (CI 0.45–0.86)
(Table 4). Irrespective of BMI, physical activity, educational
level or social class categorisation at HE1, WCG> 5 cm was
associated with a higher HR in both men and women (Ta-
bles 3 and 4 respectively). Almost 71% of women were clas-
sified as postmenopausal and a higher hazard was found in
those with a WCG> 5 cm (Table 4). Even after excluding
participants who died within 3 or 5 years of the 2HE, partici-
pants with a WCG> 5 cm had significantly higher HRs for
all-cause mortality, than those in the WCM category.
As significant findings were evident for CVD mortality
and men, but not women, in relation to changes in WC,
we further explored these in subgroups, stratified by po-
tential confounding characteristics, adjusted as per
model 3 (Additional file 1: Table S2). Generally, a higher
hazard was evident for all values of the confounding
Table 2 Associations between total and CVD mortality in 5469 men and 6868 women and categories of change in waist
circumference
Categories of change in waist circumference (WC) (cm)
Loss > 5 cm Loss > 2.5 and≤ 5 cm Loss or gain ≤2.5 cm Gain > 2.5 and≤ 5 cm Gain > 5 cm
Men, N (%) 641 (11.7) 656 (12.0) 2211 (40.4) 926 (16.9) 1035 (18.9)
All-cause mortality
Number of events 218 (34.0) 196 (29.9) 585 (26.5) 246 (26.6) 306 (29.5)
Model 1 ** 1.28 (1.09–1.49) 1.07 (0.91–1.26) Ref 1.04 (0.90–1.21) * 1.19 (1.03–1.36)
Model 2 1.14 (0.97–1.34) 1.03 (0.87–1.21) Ref 1.06 (0.91–1.23) ** 1.26 (1.10–1.46)
Model 3 0.93 (0.78–1.10) 0.95 (0.80–1.12) Ref 1.15 (0.99–1.34) *** 1.51 (1.29–1.75)
CVD mortality
Number of events 64 (10.0) 62 (9.4) 153 (6.9) 66 (7.1) 95 (9.2)
Model 1 * 1.42 (1.06–1.90) 1.28 (0.95–1.72) Ref 1.08 (0.81–1.44) ** 1.42 (1.10–1.84)
Model 2 1.22 (0.90–1.64) 1.21 (0.90–1.63) Ref 1.09 (0.82–1.46) ** 1.53 (1.17–1.98)
Model 3 0.97 (0.70–1.34) 1.11 (0.82–1.49) Ref 1.18 (0.88–1.58) *** 1.84 (1.39–2.43)
Women, N (%) 873 (12.7) 875 (12.7) 2596 (37.8) 1131 (16.5) 1393 (20.3)
All-cause mortality
Number of events 212 (24.3) 181 (20.7) 487 (18.8) 176 (15.6) 259 (18.6)
Model 1 ** 1.26 (1.08–1.48) 1.03 (0.87–1.22) Ref 0.86 (0.73–1.03) 1.09 (0.93–1.26)
Model 2 1.13 (0.95–1.33) 0.97 (0.82–1.16) Ref 0.91 (0.76–1.08) 1.15 (0.98–1.34)
Model 3 1.03 (0.87–1.24) 0.93 (0.78–1.10) Ref 0.95 (0.79–1.13) ** 1.25 (1.06–1.46)
CVD mortality
Number of events 49 (5.6) 56 (6.4) 152 (5.8) 50 (4.4) 75 (5.4)
Model 1 0.91 (0.66–1.26) 0.97 (0.72–1.32) Ref 0.81 (0.59–1.12) 1.04 (0.79–1.38)
Model 2 0.80 (0.57–1.11) 0.91 (0.67–1.24) Ref 0.87 (0.63–1.20) 1.14 (0.86–1.52)
Model 3 0.77 (0.54–1.09) 0.89 (0.65–1.22) Ref 0.87 (0.63–1.21) 1.15 (0.85–1.55)
***p < 0.001; **p < 0.01; *p < 0.05
Associations were assessed using Cox proportional hazards regression with a median follow-up from 2HE of 16 years. Results are hazard ratios and 95%
confidence intervals, HR (95% CI)
Model 1: adjusted for age (continuous)
Model 2: Model 1 + further adjusted for BMI (continuous), waist circumference (continuous), smoking (categorical), physical activity (categorical), educational level
(categorical) and social class (categorical), and menopausal status (categorical) in women
Model 3: Model 2 + further adjusted for weight change (continuous)
2HE 2nd health examination, CVD cardiovascular disease, BMI body mass index
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Table 3 Cox multivariable-adjusted HRs after 16 years of follow-up for all-cause mortality in 5469 men. Results are given for stratified
variables by WC change category
Categories of change in waist circumference (WC) (cm)





& ≤ 5 cm
gain > 5 cm
N % Deaths % HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
All 5469 100.0 1551 100.0 0.93
(0.78–1.10)
0.95 (0.80–1.12) Ref 1.15 (0.99–1.34) *** 1.51 (1.29–1.75)
By WC (1HE)
< 94 cm 2515 46.0 604 38.9 0.93
(0.67–1.28)
1.20 (0.91–1.57) Ref 1.04 (0.81–1.32) * 1.28 (1.02–1.61)
≥ 94 &≤ 102 cm 1854 33.9 520 33.5 0.93
(0.69–1.24)
0.79 (0.58–1.06) Ref * 1.34 (1.04–1.73) *** 1.96 (1.50–2.55)
> 102 cm 1100 20.1 427 27.5 0.89
(0.66–1.20)
0.90 (0.67–1.21) Ref 1.20 (0.88–1.65) * 1.42 (1.02–1.99)
By age (1HE)
< 65 y 3882 71.0 573 36.9 0.99
(0.73–1.34)
0.97 (0.73–1.29) Ref 1.22 (0.95–1.57) *** 1.78 (1.40–2.26)
≥ 65 y 1587 29.0 978 63.1 0.91
(0.74–1.13)
0.94 (0.77–1.15) Ref 1.14 (0.94–1.38) ** 1.38 (1.13–1.68)
By smoking
status (2HC)
current 438 8.0 170 11.0 0.75
(0.45–1.23)
0.98 (0.60–1.58) Ref 1.01 (0.61–1.68) ** 2.11 (1.32–3.36)
former 2970 54.3 983 63.4 0.91
(0.72–1.14)
0.89 (0.72–1.10) Ref 1.15 (0.95–1.39) *** 1.54 (1.28–1.87)
never 2061 37.7 398 25.7 1.17
(0.84–1.63)
1.08 (0.78–1.49) Ref 1.26 (0.93–1.70) 1.22 (0.89–1.67)
By BMI (1HE)
≥ 18.5 & < 25 1913 35.0 505 32.6 1.03
(0.75–1.41)
0.94 (0.70–1.26) Ref 1.03 (0.79–1.34) 1.29 (0.99–1.69)
≥ 25 & < 30 2926 53.5 831 53.6 0.80
(0.63–1.02)
0.94 (0.75–1.17) Ref 1.22 (0.99–1.50) ***1.69 (1.37–2.08)
≥ 30 630 11.5 215 13.9 1.26 (0.81–1.95) 0.89 (0.56–1.42) Ref 1.38 (0.91–2.10) 1.34 (0.88–2.04)
By physical activity (1HC)
inactive 1444 26.4 545 35.1 0.91
(0.68–1.21)
0.98 (0.74–1.30) Ref 1.21 (0.93–1.57) *** 1.72 (1.34–2.22)
mod inactive 1353 24.7 374 24.1 1.03
(0.72–1.49)
1.08 (0.79–1.47) Ref 1.14 (0.82–1.58) * 1.47 (1.07–2.03)
mod active 1377 25.2 336 21.7 0.86
(0.59–1.23
0.69 (0.47–1.01) Ref 0.95 (0.69–1.30) 1.19 (0.86–1.65)
active 1295 23.7 296 19.1 0.88
(0.57–1.33)
1.01 (0.69–1.49) Ref 1.22 (0.87–1.70) * 1.50 (1.06–2.12)
By educational
level (1HE)
No qualifications 1444 26.4 537 34.6 0.90
(0.68–1.20)
1.03 (0.78–1.36) Ref 0.90 (0.68–1.19) *** 1.76 (1.36–2.28)
O level and above 4025 73.6 1014 65.4 0.96
(0.77–1.19)
0.90 (0.73–1.11) Ref ** 1.29 (1.08–1.55) ** 1.38 (1.14–1.67)
By social class (1HE)
Non-manual 3395 62.1 932 60.1 1.03
(0.82–1.29)
0.90 (0.73–1.11) Ref 1.12 (0.92–1.37) ** 1.39 (1.14–1.69)
Manual 2074 37.9 619 39.9 0.81
(0.62–1.06)
1.04 (0.80–1.35) Ref 1.17 (0.92–1.49) *** 1.67 (1.31–2.13)
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variables in men with a WCG; findings relating to WCL
were inconsistent. In men who had a WCG > 5 cm, the
strongest associations were found in those who were
younger, current smokers, overweight, physically active,
had no qualifications, had a manual job and a normal
WC. Even after excluding participants who died within 3
or 5 years of the 2HE, men with a WCG had significantly
higher HRs for CVD mortality, than those in the WCM
category.
Total and CVD mortality: WC changes in relation to
weight changes
Weight change was strongly positively correlated with a
change in WC in both men (r = 0.60) and women (r =
0.57) (P < 0.001). We also explored the association of
category changes in WC and total mortality in combin-
ation with category changes in weight; the interaction
between WC change categories and weight change cat-
egories was not found to be significant (p = 0.29 for men
and 0.82 for women). No significant interaction was
found between WC change categories and weight
change categories with regard to CVD mortality (p =
0.71 for men and 0.52 for women).
Figure 2a illustrates the associations between category
changes in WC and weight and total mortality, adjusted
for age, BMI, baseline WC, physical activity, smoking,
educational level, social class and change in weight, and
menopausal status in women. Similar trends in both
men and women were generally evident. In men, signifi-
cantly higher HRs were observed for all WTL categories,
irrespective of whether men were categorised as WCL,
WCM or WCG, as well as for WCG and WTM (HR
1.37 (CI 1.17–1.61)), compared to those in the WTM
and WCM category. In women, significantly higher HRs
were observed for total mortality for 2 categories –
WTL and WCL (HR 1.40 (CI 1.14–1.70)) and WTL and
WCM (HR 1.50 (CI 1.16–1.95)), compared to the refer-
ence category of WTM and WCM.
Figure 2b illustrates the similar associations with CVD
mortality, adjusted for age, BMI, baseline WC, physical
activity, smoking, educational level, social class and
change in weight, and menopausal status in women. In
men, significantly higher HRs were found in the WTL
and WCL (HR 1.81 (CI 1.32–2.49)), WTL and WCG
(HR 2.22 (CI 1.03–4.82)), and WTM and WCG (HR
1.38 (CI 1.02–1.88)) categories, compared to the refer-
ence category of WTM and WCM. A significant associ-
ation for CVD mortality in women was only found in
the WTL and WCM category (HR 1.81 (CI 1.15–2.85)).
In all analyses, the category with the lowest HR was
WTG and WCL.
Discussion
Summary of main findings
In this study of 12,337 middle-aged and elderly men and
women, a WCG of more than 5 cm over approximately
4 years was associated with higher total mortality in both
men and women and higher CVD mortality in men over
the next 16 years of follow-up. Particularly among men,
the associations were also evident after stratification for
age, smoking, BMI, physical activity, educational level,
social class and after the exclusion of deaths within the
first 5 years of follow-up. Associations for WCL and
mortality were inconsistent.
Strengths and limitations
The major strengths of this study include its large popu-
lation of free-living, middle-aged and elderly men and
women, its prospective design, and the long follow-up
time. Additionally, WC, weight and height were object-
ively measured, not self-reported, and information on a
large number of factors associated with WC and weight
was available. To minimize the possibility of reverse
causality, that is, participants who were sub-clinically ill
were more likely to lose weight and WC which would
have resulted in a higher mortality risk; participants were
excluded with self-reported cancer or CVD at both
time-points, as were those who had a BMI < 18.5 kg/m2.
Those who died within the first 3 and 5 years were also
excluded in our subgroup analyses. Nevertheless, we
cannot completely rule out the possibility of some effect
of reverse causality and/or residual confounding.
Table 3 Cox multivariable-adjusted HRs after 16 years of follow-up for all-cause mortality in 5469 men. Results are given for stratified
variables by WC change category (Continued)
Categories of change in waist circumference (WC) (cm)





& ≤ 5 cm
gain > 5 cm
Excluding early deaths




Ref 1.16 (0.99–1.35) *** 1.52 (1.29–1.78)




Ref 1.13 (0.96–1.34) *** 1.45 (1.23–1.72)
Adjusted for age, BMI, baseline WC, physical activity, smoking, educational level, social class and change in weight (except where the variable was used
for stratification)
***p < 0.001; ** p < 0.01; * p < 0.05
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Table 4 Cox multivariable-adjusted HRs after 16 years of follow-up for all-cause mortality in 6868 women. Results are given for
stratified variables by WC change category
Categories of change in waist circumference (WC) (cm)






gain > 5 cm
N % Deaths % HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
All 6868 100.0 1315 100.0 1.03 (0.87–1.24) 0.93 (0.78–1.10) Ref 0.95 (0.79–1.13) ** 1.25 (1.06–1.46)
By WC (1HE)
< 80 cm 3510 51.1 516 39.2 1.14 (0.82–1.57) 1.00 (0.75–1.33) Ref 0.95 (0.73–1.23) 1.07 (0.83–1.38)
≥ 80 & ≤ 88 cm 1868 27.2 392 29.8 1.26 (0.92–1.73) 1.11 (0.81–1.51) Ref 0.78 (0.54–1.11) 1.28 (0.96–1.71)
> 88 cm 1490 21.7 407 31.0 0.80 (0.60–1.07) 0.76 (0.55–1.03) Ref 1.06 (0.76–1.47) ** 1.53 (1.11–2.11)
By age (1HE)
< 65 y 5153 75.0 518 39.4 1.23 (0.92–1.64) 1.07 (0.80–1.43) Ref 1.04 (0.80–1.36) 1.10 (0.85–1.43)
≥ 65 y 1715 25.0 797 60.6 0.92 (0.74–1.15) 0.83 (0.66–1.03) Ref 0.89 (0.70–1.12) ** 1.35 (1.10–1.67)
By smoking
status (2HC)
current 545 7.9 127 9.7 1.30 (0.78–2.15) 0.81 (0.44–1.51) Ref 1.26 (0.71–2.24) 1.15 (0.64–2.07)
former 2247 32.7 479 36.4 0.80 (0.60–1.08) 0.79 (0.60–1.06) Ref ** 0.62 (0.45–0.86) 1.14 (0.88–1.48)
never 4076 59.3 709 53.9 1.15 (0.90–1.48) 1.05 (0.83–1.33) Ref 1.13 (0.90–1.42) * 1.32 (1.06–1.65)
By BMI (1HE)
≥ 18.5 & < 25 3258 47.4 548 41.7 1.09 (0.82–1.43) 0.91 (0.69–1.19) Ref 0.93 (0.71–1.20) 1.27 (0.98–1.64)
≥ 25 & < 30 2614 38.1 540 41.1 1.04 (0.79–1.38) 1.00 (0.76–1.30) Ref 0.84 (0.62–1.13) 1.23 (0.96–1.58)
≥ 30 996 14.5 227 17.3 0.86 (0.57–1.32) 0.82 (0.52–1.29) Ref 1.17 (0.78–1.75) 1.31 (0.88–1.96)
By physical
activity (1HC)
inactive 1706 24.8 501 38.1 1.14 (0.86–1.51) 0.97 (0.74–1.27) Ref 0.97 (0.72–1.30) 1.06 (0.81–1.39)
mod inactive 2278 33.2 420 31.9 1.15 (0.83–1.58) 1.09 (0.79–1.50) Ref 1.11 (0.82–1.50) ** 1.51 (1.14–2.00)
mod active 1676 24.4 247 18.8 0.67 (0.43–1.03) 0.74 (0.49–1.12) Ref 0.70 (0.47–1.03) 1.14 (0.79–1.65)
active 1208 17.6 147 11.2 1.15 (0.70–1.92) 0.73 (0.42–1.27) Ref 0.92 (0.54–1.54) 1.41 (0.86–2.32)
By educational
level (1HE)
No qualifications 2525 36.8 670 51.0 1.07 (0.84–1.38) 0.88 (0.69–1.12) Ref 0.88 (0.68–1.12) 1.20 (0.95–1.50)
O level and above 4343 63.2 645 49.0 1.00 (0.78–1.29) 0.99 (0.77–1.27) Ref 1.02 (0.80–1.31) * 1.29 (1.03–1.63)
By social class (1HE)
Non-manual 4358 63.5 848 64.5 1.00 (0.80–1.26) 0.99 (0.80–1.22) Ref 0.80 (0.64–1.01) ** 1.30 (1.07–1.58)
Manual 2510 36.5 467 35.5 1.08 (0.81–1.44) 0.81 (0.59–1.10) Ref 1.21 (0.92–1.59) 1.14 (0.85–1.51)
Menopausal
status (2HC)
Pre-menopausal 429 6.2 9 0.7 0.00 (0.00 -) 5.16 (0.75–35.62) Ref 0.00 (0.00 -) 3.91 (0.61–24.96)
Early peri-menopausal
(< 1 y)
251 3.7 10 0.8 0.00 (0.00 -) 0.38 (0.04–4.00) Ref 0.52 (0.09–2.90) 0.77 (0.11–5.21)
Late peri-menopausal
(1–5 y)
1322 19.2 68 5.2 * 2.39 (1.00–5.69) 1.79 (0.81–3.98) Ref ** 2.84 (1.40–5.77) 1.51 (0.69–3.32)
Post-menopausal
(> 5 y)
4866 70.9 1228 93.4 1.01 (0.84–1.21) 0.89 (0.74–1.06) Ref 0.88 (0.74–1.06) * 1.23 (1.04–1.45)
Excluding early deaths
Excluding deaths < 3 y 6800 99.0 1247 94.8 1.02 (0.85–1.22) 0.94 (0.78–1.12) Ref 0.96 (0.80–1.15) ** 1.23 (1.04–1.33)
Excluding deaths < 5 y 6713 97.7 1160 88.2 1.03 (0.86–1.2) 0.94 (0.78–1.13) Ref 0.98 (0.82–1.18) * 1.24 (1.04–1.48)
Adjusted for age, BMI, baseline WC, physical activity, smoking, educational level, social class, menopausal status and change in weight (except where
the variable was used for stratification)
***p < 0.001; ** p < 0.01; * p < 0.05
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The main limitations of our study include self-reported
disease history, healthy volunteer bias and attrition. The
prevalence of self-reported CVD was lower in those who
also attended the 2HE, as was the percentage of current
smokers and physically inactive participants, which may
be indicative of healthier individuals being more likely to
return for a follow up assessment (Additional file 1: Table
1). Additionally, the percentage of deaths that occurred
was lower in both men and women, after exclusion criteria
were applied; the percentage of deaths was highest in
those who only attended the 1HE. It is possible that some
individuals in our study had undiagnosed/sub-clinical con-
ditions such as digestive disorders, or various psychosocial
diseases, such as depression, that they did not report,
resulting in weight and potentially WC loss and
subsequent death, and possibly an overestimation of the
association [39]. The more frail participants may have
been excluded and/or have not returned for the 2HC and
therefore be under-represented in our analyses. However,
it is also conceivable that some of the participants in the
weight and WC loss categories were pre-frail at 2HE. A
further limitation is the inability to account for all behav-
iour changes during follow-up, including physical activity,
which may have had effects on the observed associations.
Comparison of total and CVD mortality with other studies
The highest HRs for both total and CVD mortality in
men, which were statistically significant, were observed in
the WTL and WCG category, although this was a small
category, consisting of only 35 participants and 19 events.
Fig 2 a Total mortality in 5 469 men and 6 868 women by categories of change in weight and WC, b. CVD mortality in 5 469 men and 6 868
women by categories of change in weight and WC
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In women, the highest HR was found in the WTL and
WCM category, for both total and CVD mortality. The
category with the lowest HR in both men and women, for
both total and CVD mortality was the weight gain and
WC loss category, although this was not statistically sig-
nificant. The findings that WTL, in combination with
changes in WC, was associated with the highest HRs,
agrees with our previous study, which found that weight
loss of more than 2.5 kg over approximately 4 years is as-
sociated with a higher mortality over 15 years of follow-up
[31] in this middle-aged and elderly population.
Our findings that WCG is associated with higher all-
cause mortality are in agreement with a number of previous
publications. A recent pooled sample of 2492 Danish and
Swedish women found that WCG over 6 years was associ-
ated with increased total and CVD mortality [23]. We did
not find significant associations with WCG and CVD mor-
tality in women; statistical power was more limited due to
the lower number of CVD deaths in women in our study.
In the study of Danish and Swedish women, associations
were particularly strong for women with normal weight
and for ever-smokers. In our analyses, we found that
WCG> 5 cm had a similar HR for all BMI categories and
only never smokers had a statistically higher HR. The dif-
ferences in findings may be due to the characteristics of the
2 cohorts; our cohort of women was older, had a higher
mean BMI and a lower percentage of ever-smokers. A pro-
spective study of 26,625 healthy middle-aged men and
women has also shown that increases in WC over a 5.3 year
period were positively associated with mortality in men and
women over 6.7 years of follow-up; the HR was 1.09 (1.02,
1,16) per 5 cm for both men and women combined, after
adjusting for baseline BMI, WC and change in BMI [24].
However, results from the Melbourne Collaborative
Cohort Study of 21,298 men and women aged 40–69
years at baseline found that WCL over approximately
12 years was associated with an increased risk of all-
cause mortality (HR: 1.26; 95% CI: 1.09–1.47) over 7.7
years of follow-up, especially in older adults, compared
to those who had minimal changes, but did not find an
association with WCG [25]. It is possible that the shorter
time period of less than 4 years between our WC mea-
surements may partially explain our lack of associations
with WCL and mortality. However, in a study of older
adults aged 70–77 years, WCL over a 3 year period (≥3.1
cm) was significantly associated with an all-cause mor-
tality risk over 20 years of follow-up of 1.52 (95% CI:
1.01–2.31), which was comparable to their weight loss
finding, in agreement with our previous results [31]; no
significant associations were found for WCG and all-
cause mortality, or changes in WC and CVD mortality
[40]. No significant associations were found with self-
reported changes in WC over a 12 years and concurrent
mortality, after 9 years of follow-up, in a large,
prospective study among 23,254 Swedish women [26],
although the cohort was relatively young (median age of
52 years at follow-up), with a relatively low number of
deaths (N = 570) during follow-up, of which 79 were at-
tributable to CVD. A smaller study of 1138 older adults,
predominantly female, from the Bambuí (Brazil) Cohort
Study of Aging [27] did not find any associations with
WC change and mortality; the relatively short time
interval of 3 years between measurements, in addition to
the follow-up period of 8 years may have contributed to
the lack of findings. No associations were found for WC
change over 3.6 years and mortality in a study of 1805
Iranian men, aged ⩾30 years [28]; the limited number of
deaths (N = 88) during the relatively short-term follow-
up of 6.6 years resulted in limited power to assess the ef-
fect of changes in WC for mortality events.
Changes in WC and weight and plausible mechanisms
Weight, particularly in older populations, is an indicator
encompassing not just fat but also bone and muscle
mass and these different components may relate to
health in different directions; thus, weight loss in later
life may be an indicator of increasing frailty. Body fat
distribution changes with age, with a reduction in sub-
cutaneous fat and an increase in central adiposity [41].
The accumulation of body fat in the abdominal region
has been shown to be associated with a number of ad-
verse health outcomes such as diabetes, metabolic syn-
drome, CVD and all-cause mortality, independently of
BMI [12, 42–44]. Adipose tissue has an important role
to play in numerous metabolic and endocrine functions,
including the expression and secretion of inflammatory
cytokines, such as leptin, adiponectin, and interleukin 6
(IL-6), which are important regulatory factors of energy
intake and inflammatory responses [45]. In a study of 20
abdominally obese, older women, hyperinsulinemia was
positively associated with adipose IL-6 gene expression,
but negatively associated with adipose adiponectin ex-
pression [46]. A 20-week weight loss program in obese,
older women decreased leptin production in both gluteal
and abdominal adipose tissue, but only increased adipo-
nectin production from abdominal adipose tissue [47].
These results highlight the importance that regional adi-
pose tissue hormone/cytokine production may play in
mechanisms of metabolic complications associated with
abdominal obesity and the importance of improving
body fat distribution, through appropriate exercise and
diet programs [48].
Public health considerations
Obesity is a complex condition, for which there are numer-
ous risk factors, many of which are modifiable [49, 50]. At-
tention needs to be focussed on various levels of policy
strategies for its prevention [51, 52]. Aa a number of studies
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have shown that WC is increasing at a faster rate than BMI
or body weight [53–55], current recommendations, based
on observational cohort studies, including findings from this
publication, should advocate prevention of WC gain into
adulthood, and weight and WC stability from midlife
onwards.
Conclusion
In summary, an increase in WC of more than 5 cm over
approximately 4 years, with little weight gain, is signifi-
cantly associated with higher total mortality in both men
and women and higher CVD mortality in men over the
next 16 years of follow-up in this population-based co-
hort study of 12,337 middle-aged and elderly men and
women. These findings are in marked contrast to our
earlier observation that weight loss is associated with in-
creased mortality risk [31]. The apparently paradoxical
observations suggest that WC may be a better indicator
of the adverse health consequence of obesity in later life
than weight. Interventions targeted at fat distribution
and focusing on preventing increase in central adiposity
rather than lowering weight per se in later life may be
more likely to have health benefits.
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